MAB21L2

MAB21L2 is a conserved single-stranded RNA-binding protein that controls progenitor cell proliferation and survival across multiple developing tissues, with its principal characterized role in eye morphogenesis (PMID:24906020, PMID:15385160). It binds single-stranded RNA in vitro—an activity abolished by disease-associated missense variants—but shows no detectable nucleotidyltransferase activity (PMID:24906020). Functionally, MAB21L2 antagonizes BMP4/SMAD signaling: it physically associates with SMAD1 and the SMAD1–SMAD4 complex, acts as a transcriptional repressor when tethered to a promoter, and rescues BMP4-induced axial dorsalization in Xenopus (PMID:15613244). In eye development it operates downstream of Rx3 and upstream of Chx10, where its loss causes deficient optic vesicle invagination, increased apoptosis of eye progenitors, and microphthalmia/anophthalmia, while regulating proliferation, cell-cycle exit, and differentiation in retina, lens, and cornea (PMID:15183718, PMID:15385160, PMID:30073347, PMID:31037784). Beyond the eye, MAB21L2 drives proliferation in cardiomyocytes and the proepicardium/septum transversum mesenchyme, hepatoblasts, and limb-bud chondrocyte precursors (PMID:22412967, PMID:40054064). The chaperones HSPA8 and HSPA5 are direct binding partners relevant to its ocular function, and eye-specific expression is governed by a distal Otx2-bound regulatory element whose disruption causes microphthalmia and coloboma (PMID:36576422, PMID:39455595). Loss of human MAB21L2 function or its regulatory elements causes ocular malformations including microphthalmia and coloboma (PMID:24906020, PMID:39455595).

1. 2004 Medium

   Establishing what biochemical activity MAB21L2 carries, the protein was shown to bind single-stranded RNA while lacking nucleotidyltransferase activity, redefining its molecular identity away from a presumed enzyme.

   Evidence In vitro RNA-binding and nucleotidyltransferase assays with structural homology modeling, including disease variants

   PMID:24906020

   Open questions at the time

   • No RNA target specificity or sequence motif identified
   • Functional consequence of RNA binding for downstream signaling not established
   • Single lab, abstract-level methodological detail
2. 2004 Medium

   To place MAB21L2 in a signaling pathway, it was shown to antagonize BMP4 by binding SMAD1/SMAD1-SMAD4 and acting as a transcriptional repressor, connecting it to TGF-beta/BMP signal output.

   Evidence Xenopus overexpression rescue, in vivo Co-IP and in vitro binding with SMAD1/SMAD4, heterologous promoter repressor assay

   PMID:15613244

   Open questions at the time

   • Target genes repressed by MAB21L2 not defined
   • Mechanism linking RNA binding to SMAD repression unknown
   • Direct DNA binding not demonstrated
3. 2004 Low

   Genetic epistasis in C. elegans placed mab-21 orthologs downstream of or parallel to TGF-beta pathway components, supporting a conserved role in signaling-dependent organ patterning.

   Evidence C. elegans double-mutant epistasis cited from prior literature

   PMID:15613244

   Open questions at the time

   • Epistasis data cited, not directly performed in this corpus
   • Molecular relationship to mammalian BMP signaling indirect
4. 2004 Medium

   Positioning MAB21L2 in the eye gene network, it was shown to act downstream of rx3 and to be required for survival of eye progenitors, defining it as an early effector of retinal field specification.

   Evidence Zebrafish morpholino knockdown, in situ hybridization in rx3 mutants, apoptosis assays

   PMID:15183718

   Open questions at the time

   • Morpholino knockdown not confirmed by stable mutant in this study
   • Direct transcriptional regulators downstream of MAB21L2 not defined
5. 2004 Medium

   A mouse knockout established that MAB21L2 drives optic vesicle invagination through proliferation and lies upstream of Chx10, distinguishing it from Rx/Lhx2/Pax6 inputs.

   Evidence Mouse genetic knockout with histology and marker in situ hybridization

   PMID:15385160

   Open questions at the time

   • Mechanism linking MAB21L2 to Chx10 regulation unknown
   • Whether effect is cell-autonomous not resolved
6. 2012 Medium

   Extending MAB21L2 beyond the eye, knockout mice revealed requirements for proliferation in heart, proepicardium/septum transversum mesenchyme, and liver, defining a broad role in progenitor proliferation.

   Evidence Mouse genetic knockout with histology, gene expression, and integrin immunostaining

   PMID:22412967

   Open questions at the time

   • Molecular pathway linking MAB21L2 to α4 integrin and proliferation not defined
   • Direct versus indirect effects on each tissue unresolved
7. 2018 Medium

   Chick loss- and gain-of-function defined a stage-dependent requirement for MAB21L2 in regulating proliferation, cell-cycle exit, and differentiation across retinogenesis.

   Evidence In ovo RNAi and overexpression electroporation with proliferation/differentiation markers

   PMID:30073347

   Open questions at the time

   • Direct transcriptional targets among affected markers not established
   • Mechanism of bidirectional dose sensitivity unknown
8. 2019 Medium

   Zebrafish mutants dissected tissue-specific MAB21L2 roles, linking it to lens proliferation/survival, choroid fissure basement-membrane breakdown (coloboma), and corneal stromal differentiation.

   Evidence Zebrafish genetic mutant with proliferation/apoptosis assays and marker analysis

   PMID:31037784

   Open questions at the time

   • Molecular control of basement-membrane breakdown not defined
   • Cell-autonomy of corneal phenotype unresolved
9. 2023 Medium

   Interactome screens identified physical partners including HSPA8/HSPA5, and double-mutant genetics linked hspa8 to MAB21L2 in eye development, providing a chaperone-associated molecular context.

   Evidence Yeast two-hybrid, Co-IP, mass spectrometry, and zebrafish double-mutant analysis

   PMID:36576422

   Open questions at the time

   • Functional consequence of HSPA8/HSPA5 binding unknown
   • Roles of klhl31/tnpo1/TNPO2/KLC2/SPTBN1 interactions not characterized
10. 2024 Medium

    Identifying how MAB21L2 eye expression is controlled, a distal Otx2-bound conserved element (CE14) was shown to be a functional regulatory element whose disruption causes ocular defects.

    Evidence Human deletion mapping, ChIP-seq for Otx2, CRISPR disruption of CE14 in Xenopus

    PMID:39455595

    Open questions at the time

    • Direct Otx2 regulation of MAB21L2 in human cells not shown
    • Roles of other conserved elements not tested
11. 2025 Medium

    Conditional knockout extended MAB21L2 function to skeletal development, showing it promotes chondrocyte proliferation in limb stylopod formation, likely non-cell-autonomously.

    Evidence Prx1-Cre conditional knockout mouse with micro-CT and proliferation assays

    PMID:40054064

    Open questions at the time

    • Non-cell-autonomous signal not identified
    • Mechanism linking MAB21L2 to chondrocyte proliferation unknown
12. 2026 Low

    MAB21L2 was implicated in cancer, with knockdown inhibiting neuroblastoma growth and migration, suggesting a pro-tumorigenic role.

    Evidence siRNA/shRNA knockdown, xenograft, RNA-seq, migration assay in neuroblastoma cells

    PMID:41651436

    Open questions at the time

    • No mechanistic pathway placement in cancer
    • Single lab, limited validation
    • Relationship to developmental BMP/proliferation roles unclear

• How MAB21L2's RNA-binding activity mechanistically connects to its SMAD-repressing, proliferation-promoting functions across diverse tissues remains unresolved.
• No RNA target identified that links biochemistry to transcriptional/proliferative output
• No structural model of partner or RNA engagement in cells
• Unified mechanism across eye, heart, liver, limb, and cancer not established